Robyn Kendall

6PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Infant and child healthToxicology (incl. clinical toxicology)Semi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 20, 2025
Efficacy of Biologics for the Treatment of Moderate-To-Severe Plaque Psoriasis in the Asian Population: A Systematic Review and Network Meta-Analysis.

Akihiko Asahina, Mir Sohail Fazeli, Robyn Kendall

|Jun 24, 2025
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.

Kai-Michael Beeh, Jing Claussen, Dhvani Shah

|Jan 24, 2025
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico.

José Luis Huerta, Robyn Kendall, Luka Ivkovic

|Aug 28, 2023
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK.

Robyn Kendall, Alan A Martin, Dhvani Shah

|Nov 01, 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.

David M G Halpin, Robyn Kendall, Soham Shukla

|Dec 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.

Soham Shukla, Dhvani Shah, Alan Martin

Pageof 1

Frequent Collaborators

4 joint publications

Alan Martin

4 joint publications

Afisi S Ismaila

3 joint publications

Soham Shukla

2 joint publications

Paul W Jones